Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 71Colorectal Neoplasms 34Rectal Neoplasms 33Esophageal Neoplasms 25Carcinoma, Non-Small-Cell Lung 24Esophageal Squamous Cell Carcinoma 23Pancreatic Neoplasms 16Stomach Neoplasms 15Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Adenocarcinoma Of Esophagus 14Sarcoma 11Ovarian Neoplasms 11Lung Neoplasms 11Colonic Neoplasms 11Carcinoma, Hepatocellular 11Prostatic Neoplasms 10Head and Neck Neoplasms 10Neoplasm Metastasis 9Urinary Bladder Neoplasms 8Uterine Cervical Neoplasms 7Recurrence 6Osteosarcoma 6Multiple Myeloma 5Fallopian Tube Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 5Breast Carcinoma In Situ 5Peritoneal Neoplasms 4Nasopharyngeal Carcinoma 4Locally Advanced Rectal Cancer 4

Interventions

Liver Transplantation 4Gemcitabine 4Cisplatin 4Capecitabine 4Radiosurgery 3toripalimab 2Specimen Handling 2Self Expandable Metallic Stents 2Platinum 2Oxaliplatin 2Magnetic Resonance Spectroscopy 2Fluorouracil 21,2-diaminocyclohexaneplatinum II citrate 2trisacryl gelatin microspheres 1tremelimumab 1tislelizumab 1temoporfin 1sacituzumab govitecan 1ricolinostat 1pembrolizumab 1lenvatinib 1gemcitabine-oxaliplatin regimen 1fludarabine 1durvalumab 1Saline Solution 1Radiofrequency Ablation 1Photosensitizing Agents 1Photochemotherapy 1Pancreatic Hormones 1Optical Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Klatskin Tumor × Neoadjuvant Therapy × Clear all
NCT02178280 2014-06-30

Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 1/2 Unknown
60 enrolled
Gastrointestinal

Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡